Member Login

Forgot Password
Join ICHP

ICHP

ICHP Illinois Council of Health-System Pharmacists

Advanced Search

* Member Only Content
** Board, Division and Committee Members only

Professional Practice » ICHP Position Statements »

DIRECT TO COMSUMER ADVERTISING OF PRESCRIPTION AND NONPRESCRIPTION MEDICATIONS

The Illinois Council of Health-System Pharmacists (ICHP) supports the American Society of Health-System Pharmacists' (ASHP) position on Direct-to-Consumer Advertising. ICHP has adopted the same language as ASHP on this statement.

To support direct-to-consumer advertising that is educational in nature about prescription drug therapies for certain medical conditions and that appropriately includes pharmacists as a source of information; further, to support direct-to-consumer advertising of specific prescription drug products only when the following requirements are met: (1) that such advertising is delayed until post-marketing surveillance data are collected and assessed, (2) that the benefits and risks of therapy are presented in an understandable format at an acceptable literacy level for the intended population, (3) that such advertising promotes medication safety and allows informed decisions, and (4) that a clear relationship between the medication and the disease state is presented; further, to support the development of legislation or regulation that would require nonprescription drug advertising to state prominently the benefits and risks associated with product use that should be discussed with the consumer's pharmacist or physician.

Approved 09/2007

Email Page Print Page